CompaniesAmomed Pharma

Amomed Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

495

By Phase

PHASE3: 2

By Status

ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT01032304
Hover over trial bars to see details

Recent Trials

NCT06582524Lead Sponsor
Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency
PHASE3Active, not recruiting
3 participants
Started: Aug 30, 2024 · Completed: Oct 1, 2025
NCT01032304Lead Sponsor
The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)
PHASE3Unknown
492 participants
Started: Aug 31, 2009 · Completed: Sep 30, 2015
Related Companies
Aop
acquired